MDCX

Medicus Pharma Ltd. Common Stock

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mehmud FaisalChief Medical Officer
--250k shares
Grant / ExerciseJun 3, 2026
$90.0K250k shares
$0.36
--
Smith Andrew AlasdairChief Operating Officer
--200k shares
Grant / ExerciseJun 3, 2026
$72.0K200k shares
$0.36
--
Mahaffy Patrick JDirector
--50k shares
Grant / ExerciseJun 3, 2026
$18.0K50k shares
$0.36
--
May Sara R.Director
--50k shares
Grant / ExerciseJun 3, 2026
$18.0K50k shares
$0.36
--
Raju AjayDirector
--50k shares
Grant / ExerciseJun 3, 2026
$18.0K50k shares
$0.36
--
Rodgers Cathy McMorrisDirector
--50k shares
Grant / ExerciseJun 3, 2026
$18.0K50k shares
$0.36
--

News

proactiveinvestors.comMedicus Pharma submits EU clinical trial modification for prostate cancer drug Teverelixproactiveinvestors.comJun 8globenewswire.comMedicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submissionglobenewswire.comJun 8proactiveinvestors.comMedicus Pharma advances SkinJect for Gorlin syndrome – ICYMIproactiveinvestors.comJun 6proactiveinvestors.comMedicus Pharma advances SkinJect for Gorlin syndrome – ICYMIproactiveinvestors.comJun 6proactiveinvestors.comSolidion Technology shares surge after company unveils extreme-climate battery technologyproactiveinvestors.comJun 4